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ABSTRACT 
The PFC Sigma Cobalt Chrome Sigma (PFCSCC) was introduced in 2006, and represents further development 
of the PFC Sigma design aiming at reducing the problem of backside wear. To ensure that there were no signifi- 
cant early failures following the introduction of this knee system to our hospital in 2006, we prospectively identi- 
fied all patients undergoing TKA with the PFCSCC over a one-year period. Clinical and demographic patient 
data, American Knee Society scores, Oxford Knee scores, SF-12 scores and radiographic data were recorded 
pre-operatively and at three-year post surgery. 233 patients underwent 249 primary knee arthroplasties with the 
PFCSCC. Seven patients (eight TKAs) died before the last review and eight cases were lost to follow up. Mean 
age was 66.7 (range 34 - 80) with 47.6% male. Mean follow-up days were 1109 (range 741 to 1591). 5 (2.2%) were 
revised for infection with 1 revised for pain. The 3-year survival rate was 97.6% and 99.6% for aseptic failure. 
AKS 46.2 (0 - 95) was preoperatively 88.3 (17 - 100) with 3 years P < 0.001. OKS 39.0 (22 - 53) was preoperatively 
22.6 (12 - 53) with 3 years P < 0.001. 17 of the 219 who had x-rays (8%) had radiolucent zones on x-ray. Our re- 
sults demonstrate a good early aseptic survivorship of the PFCSCC at three years of 99.6%, combined with a 
good functional and objective improvement in our patients in three years. 
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1. Introduction 
Total knee arthroplasty is well established for relieving 
pain and improving function. The Press Fit Condylar (PFC) 
Sigma total knee arthroplasty (TKA) (Depuy, Johnson & 
Johnson) is the most widely implanted knee prosthesis in 
England and Wales, and accounts for 36% of all the TKAs 
performed in 2009 [1]. The PFC Sigma Cobalt Chrome 
(PFCSCC) TKA was introduced in 2006 and represents a 
design modification based upon the PFC Sigma. 
The tibial tray for the PFCSCC TKA is made of a co- 
balt chrome alloy, whereas in the older PFC Sigma, the 
tray was made of titanium. The theoretical advantage of 
this design modification is that microscopically the co-  
balt chrome alloy is smoother than titanium and therefore 
less likely to produce backside wear of the polyethylene 
insert [2]. In addition, the PFCSCC polyethylene insert is 
exposed to a higher radiation dose than the previous PFC 
Sigma insert, theoretically resulting in an extended life- 
time of the prosthesis. The locking mechanism between 
the insert and tibia tray has also been improved to mi- 
nimize backside wear. 
Minor changes in arthroplasty can lead to unexpected 
early catastrophic failure and change the survivorship of 
implants [3]. Many implants undergo minor changes and 
it is important to ensure that these changes do not cause 
early failure [4]. National joint registries [1] may not 
identify all minor changes and outcomes after a short 
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period. Therefore, early clinical results in peer-reviewed  
journals represent an important method of informing 
surgeons about the initial survivorship and outcomes of 
newly introduced changes in the implant design and 
manufacture process [4]. We report the first early clinical, 
radiological and patient reported results for the PFCSCC 
TKA in 3 years, in order to allow comparison with pub- 
lished data on its predecessor, the PFC Sigma TKA. 
2. Methods 
Prospective data have been collected on all primary 
TKAs performed in our hospital since 1996. The PFCSCC 
(Depuy, Johnson & Johnson) TKA was introduced in our 
hospital in February 2006. Between February 2006 and 
February 2007, 249 primary knee arthroplasties with the 
PFCSCC TKA were performed on a total patient cohort 
of 233. Sixteen patients underwent bilateral primary pro- 
cedures. No other TKA implant designs were used during 
this time period. 
Demographic and clinical data, American Knee So- 
ciety (AKS), Oxford Knee (OKS) and Short Form-12 
Items Survey (SF-12) scores were collected prospective- 
ly from all patients on admission and at follow up clinics 
at six months, 18 months and three years. At final review, 
the AKS score was calculated using the protocol de- 
scribed by Install et al. [5], and standard short leg ante- 
rioposterior and lateral radiographs were obtained. Ra- 
diographic measurements of varus and valgus angulation, 
flexion or extension of the tibial and femoral components 
were taken. Radiolucencies were sought at the bone/ce- 
ment and cement/prosthesis interfaces of both components. 
Eight different operating surgeons, either consultant 
grade or a trainee under direct supervision, performed the 
operations. All surgeons used the same instrumentation 
and patients underwent the same postoperative regimen. 
The operations were performed in a filtered air operating 
theatre with laminar flow. Waterproof single use gowns 
and drapes were used and both the surgeon and assistant 
were double gloved. A tourniquet was used routinely, 
and the femoral and tibial cuts were performed using 
intramedullary and extramedullary alignment, respec- 
tively. The patella was not routinely resurfaced, but this 
was carried out at the discretion of the operating surgeon 
when patella wear was severe. All patients had antibiotic 
prophylaxis with 1 g Ceftriaxone shortly before inflation 
of the tourniquet. Pre- and post-operative thromboem- 
bolic prophylaxis was administered in the form of using 
low molecular weight heparin and full-length graded 
elastic stockings [6]. Wounds were dressed with gauze, 
wool and crepe dressings. These dressings were removed 
on the first post-operative day and continuous passive 
mobilisation was commenced. Blood transfusion was 
only performed if the haemoglobin fell below 8.5 g/dl. 
Statistical Methods 
Continuous data were presented in terms of the mean and 
range (R). Mean values between groups (AKS scores, 
OKS, SF-12 scores) were compared using the t-test for 
two groups and the analysis of one-way variance (ANO- 
VA) for three or more groups. A p-value of <0.05 deter- 
mined statistical significance. Life tables were con- 
structed and the cumulative survival rates were calcu- 
lated. Endpoints chosen were “reoperation for any reason” 
and “component revision for aseptic loosening or me- 
chanical failure”. The Rothman method [7,8] was used to 
calculate 95% confidence intervals. A “worst case” sur- 
vival analysis was also performed based on the assump- 
tion that all those lost to follow up had failed immediate- 
ly after the time of their last appointment. 
3. Results 
Two hundred and forty-nine PFCSCC TKAs were per- 
formed on 233 patients, 122 (52.4%) of whom were wo- 
men. The indication for surgery was osteoarthritis in 226 
(97.0%) patients, rheumatoid arthritis in five (2.1%) cas- 
es and avascular necrosis in two (0.9%). The mean pa- 
tient age was 66.7 years (R 34 - 80 yr). The mean pa- 
tient body weight was 83.2 kilograms (R 49 - 130 kg) 
and the mean body mass index (BMI) was 30.0 kg/m2 (R 
20.7 - 40.1 kg/m2). 
Two hundred and forty-one TKAs in 226 patients were 
available for review at three years. The mean follow up 
was 1109 days (R 741 - 1591 days). The AKS score im- 
proved from 46.2 (R 0 - 95) pre-operatively to 88.3 (R 17 
- 100) at final review (p < 0.001, t-test). The OKS 
(available for 203 patients) improved from 39.0 (R 22 - 
53) pre-operatively to 27.6 (R 14 - 53) at three months, 
and 23.4 (R 12 - 53) at one year (p < 0.001, ANOVA). 
The patient mean pain score at admission was 11.7 
(range 0 - 45) at 3 years: 39.5 (range 0 - 50) (p < 0.001). 
Function score mean at admission 43.5 (range −20 - 85). 
59.5 (range −20 - 90) at 3-year follow up (p < 0.001). 
Table 1 (Top) shows the mean patient reported SF-12 
scores for 201 patients. By the three months post-opera- 
tive time point, there was a statistically significant im- 
provement in all SF-12 domains except the Mental 
Health score and General Health score. However, be- 
tween the three months and one-year time points, the 
only SF-12 domains, which displayed a significant im- 
provement, were the Physical Functioning and Pain 
scores. 
Eight TKAs were lost to follow-up, five underwent re- 
vision for infection, and one was revised for persistent 
pain (Table 2). The three-year survival rate was calcu- 
lated as 97.6% with “reoperation for any reason” (Figure 
1) and 99.6% with “component revision for aseptic loo- 
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Table 1. The mean SF-12 scores in each domain at the time of admission, and at three months, one year and three years. 
p-values for comparisons between selected mean values were calculated using t-tests. (Physical Functioning score [PF], Role 
Limitation Physical score [RP], Pain score [BP], General Health score [GH], Vitality score [VT], Social Functioning score 
[SF], Role Limitation Emotional score [RE] and Mental Health score [MH]). 
SF-12 Domains Admission 3 Months 1 Year 3 Years Admission versus 3 months 
3 months versus 1 
year 
1 year versus 3 
years 
PF 6.2 49.3 55.7 51.4 <0.001 0.007 0.09 
RP 3.9 44.9 48.6 48.6 <0.001 0.28 0.51 
BP 36.4 62.5 74.5 70.8 <0.001 <0.001 0.25 
GH 68.4 66.4 65.0 60.3 0.38 0.24 0.020 
VT 45.5 52.9 56.2 53.2 <0.001 0.07 0.11 
SF 52.4 74.9 77.5 76.1 <0.001 0.30 0.69 
RE 96.1 76.1 79.0 75.4 <0.001 0.34 0.51 
MH 69.8 72.3 74.9 72.6 0.12 0.10 0.13 
 
Table 2. The life table calculation for survival of the PFC Sigma Cobalt Chrome TKA, with chosen endpoints “reoperation 
for any reason”, “component revision for aseptic loosening or mechanical failure” and “worse case” survival where all the 
knees lost to follow-up were assumed to have failed. (*Number of knee prosthesis implanted). 
Year No.* at start Death 
Lost to 











aseptic failure # 
1 249 1 3 6 247 2.4% 97.6% 97.6% 96.4% 99.6% 
2 239 2 0 0 238 0.0% 100.0% 97.6% 96.4% 99.6% 
3 236 5 5 0 231 0.0% 100.0% 97.6% 94.3% 99.6% 
 
 
Figure 1. The three-year survival of the PFC Sigma Cobalt 
Chrome TKA with the endpoint taken as “reoperation for 
any reason”. Error bars indicate 95% Confidence Interval. 
 
sening or mechanical failure” (Figure 2). The “worse 
case” survival was 94.3% at three years where all the 
knees lost to follow-up were assumed to have failed. 
Radiographic data were available for 219 TKAs 
(88.0%) at final review. Of these 17 radiolucencies were 
noted in 17 (8%) cases. The mean mediolateral alignment 
was 5.2 degrees valgus (2 Degrees Varus to 9 Degrees 
Valgus.) In this series, 22 (10%) knees were out-with the 
suggested range of 7˚ +/− 3˚ [11]. There was no evidence 
of increased incidence of radiographic lucency in these 
knees. 
4. Discussion 
We present the first early clinical, radiological and pa- 
tient reported results for the PFCSCC TKA. We have 
previously reported on the medium- to long-term follow 
up of the PFC Sigma TKA [9-13]. The design of the PFC 
Sigma Cobalt Chrome TKA incorporates a number of 
minor modifications from the PFC Sigma TKA and these 
initial results show that at three years post-operatively, 
the prosthesis survival rate stands at 97.6% with revision 
for any reason and 99.6% with revision for aseptic failure. 
This is comparable to our experience with the PFC Sig- 
ma where there were a small number of failures, mostly 
in the early period. This would suggest that the design 
changes have not caused any increase in early failures. 
There are few papers which describe the early results 
of total knee replacements, however when compared to 
Munziger et al. 2010 [14], their 5 year results of the In- 
nex total knee replacement demonstrated a 3% aseptic 
revision rate and a 4.8% overall revision rate, whereas 
our results compare favorably at the moment and show 
no initial early failures. The Munziger et al. 2010 [14] 
paper, showed that all their infective revisions were in 
the first 4 months and after discussing with the authors, 6 
out of 9 aseptic revisions were within the 3 years, and 
these were due to overstuffing, instability anterior knee 
pain or arthrofibrosis. This paper does confirm the need  
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Figure 2. The three-year survival of the PFC sigma cobalt 
chrome TKA with the endpoint taken as “component revi- 
sion for aseptic loosening or mechanical failure”. Error 
bars represent 95% confidence interval. 
 
to produce five year results to ensure that there is no mid- 
term peak in revisions. Apart from our own results, there 
have been other medium term results published for the 
predecessor to the PFCSCC, the PFC Sigma, with Dalury 
et al. [15] reporting 99.6% and Zaki et al. [16] reporting 
99.4% survivorship in the medium term and our revisions 
for aseptic reasons currently remain on track to be similar 
to their findings. All of our aseptic failures, required a 
change of the polyethylene spacer only, with none re- 
quiring revision of the tibial or femoral components. This 
comparison is reassuring, following the design modifica- 
tions made in changing from PFC Sigma to the PFC 
Sigma Colbalt Chrome, as there appears to be no drop in 
survival of the prosthesis during the first 3 years. 
There were 8 knees (3%) lost to follow-up during the 
study period, which highlights the problems with longi- 
tudinal studies and represents a weakness in our study. 
As revision rates are very low, failure to identify a revi- 
sion from the study group would have a significant effect 
on the results. If we take a “worst case” scenario, assum- 
ing all lost knees were revised, this would give us a sur- 
vival rate of 94% at three years. This would still re- 
present an acceptable performance at three-year post im- 
plantation. 
The clinical outcomes were assessed using the Ameri- 
can Knee Society scoring system and the results showed 
pre-operatively the mean AKS Score was 46.2 whilst at 3 
years post-operatively, the mean AKS was 88.3. These 
early results suggest considerably better outcomes than 
Zaki et al. 2007 [16], and Hunter et al. 2009 [9], who 
reported an AKS score at 7 - 9 year review for the PFC 
Sigma and the result compares well with the Wrighting- 
ton study [16,17] which had a mean score of 50 and Da- 
lury’s results [14] which had a mean score of 50 [15]. 
The American Knee Society Scoring system is sepa- 
rated into a Knee score and the Function Score to prevent 
confounding of the Knee Scores by increasing infirmity,  
and we showed a significant improvement in both Knee 
Score (mean of 46.2 with a range of 0 - 95 to a mean of 
88.3 with a range of 17 - 100 at 3 years) and Function 
Score (mean of 43.5 with a range of −20 - 85 to a mean 
of 59.5 with a range of −20 - 90 at 3 years). The mean 
pain score at admission to 3 year review was significant- 
ly increased from 11.7 to 39.5. Our results for the PFC 
sigma ten year results [10] showed a mean function score 
of 79.9 at 18 months post surgery which then declined to 
68.9 at 10 years. Our initial results for the PFCSCC per- 
form favourably when compared to the PFC Sigma, but 
Arthur et al. 2013 [11] study highlights the importance of 
continuing to review the AKS for the PFCSCC in order 
to ensure the scores do not decrease more than expected 
over time. 
The Oxford Knee Score showed a highly significant 
improvement [16] between the pre-operative score and 
the scores at 3 months, and the 3-month score and the 
score at 1 year but there was no significant difference 
between 1 year and at 3 years, this information is impor- 
tant for patients as it demonstrates that up to one year 
patients can expect improvements, however these will 
stabilise out between 1 and 3 years. Our early results 
were better than the mean Oxford Knee Score for the 
PFC Sigma at 7 - 9 years [9] and so further research will 
be required at the ten year mark to ascertain if these early 
improvements are maintained or diminish. 
We used the SF-12 [18] to measure health status and 
the 3 month review showed significant improvements in 
all domains except Mental and General Health. After the 
three month mark the only ongoing significant improve- 
ment was an increase in the pain score demonstrating that 
there was an improvement in pain, which continued up to 
1 year whilst these are early results, they are still relevant 
as early results have been shown to be predictive of 
overall satisfaction rate by Scott et al. 2010 [19]. 
Radiographs of the study group were also available for 
review and 219 knees of the 235 surviving knees were 
analysed. 22 knees (10%) were outside the suggested 
range (7 +/− 3◦) for mediolateral alignment. This figure 
compares well to other TKA series using the same defi- 
nition that reported that only 22% - 34% lie in this range 
[20-23]. The standard radiographs taken in our unit are 
short leg films instead of long leg films, which has the 
limitation of overestimating varus alignment of the knee 
by approximately 1.6◦. It is likely that our numbers would 
be lower if long leg films had been used as standard. 
5. Conclusion 
With escalating healthcare costs combined with multiple 
minor changes to implants, it is essential that we ensure 
that small changes to the implants are not going to cause 
early failures in order to prevent multiple costly revisions 
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in both monetary and patient morbidity terms. These 
early results come from the first consecutive cohort of 
patients using a new implant, with a follow-up rate of  
97% that allows a reliable assessment of the initial effi- 
cacy of this prosthesis. These early results should be re- 
produceble in a district general orthopaedic unit. We 
conclude that the new PFC Sigma Colbalt Chrome knee 
arthroplasty performs well over the first 3-year post im- 
plantation with excellent survival rates and good clinical 
and radiological outcomes and that ongoing follow-up is 
required to ensure that it continues to maintain this stan- 
dard. 
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